Modeling the protective effect of previous compulsory smallpox vaccination against human monkeypox infection: from

Tibor Spath1, Sophie Brunner-Ziegler2, Tanja Stamm3

  • 1Medical University of Vienna, Department of Hospital Epidemiology and Infection Control, Vienna, Austria.

Abstract

Insights

Smallpox vaccination offers limited protection against monkeypox (MPX) in Austria, with only 50.4% efficacy in those vaccinated before 1981. Current vaccination status alone is insufficient to contain MPX outbreaks without additional public health measures.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Human monkeypox (MPX) cases are increasing globally.
  • Smallpox vaccination, compulsory in Austria until 1981, provides an estimated 85% cross-protection against MPX.

Purpose of the Study:

  • To assess the impact of smallpox vaccine-induced immunity on MPX transmission in Vienna, Austria.
  • To determine age-dependent immunity and infection probability in the general population.

Main Methods:

  • Utilized a modified susceptible-infected-removed (SIR) model.
  • Analyzed age-specific vaccine-induced protection and infection probability.

Main Results:

  • Average vaccine-induced protection was 50.4% in individuals born before 1981; no protection was observed in those born after.
  • The overall probability of infection post-exposure was 73.8%, exceeding the threshold for sustained transmission (R ≥1.0).

Conclusions:

  • Population immunity from smallpox vaccination alone is insufficient to contain MPX.
  • Additional containment measures are crucial to prevent widespread dissemination, especially given increasing incidence.
  • The model provides a framework for risk assessment adaptable to other populations globally.